Optimization of psoriasis mouse models
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 108, 107054
Abstract
No abstract availableKeywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Animal models of human disease: Challenges in enabling translationBiochemical Pharmacology, 2014
- Hypercholesterolemia and Risk of Incident Psoriasis and Psoriatic Arthritis in US WomenArthritis & Rheumatology, 2013
- Epicutaneous Application of Toll‐like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild‐Type Mice: A New Model of Systemic Lupus ErythematosusArthritis & Rheumatology, 2013
- TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasisEuropean Journal of Immunology, 2013
- Psychological differences between early- and late-onset psoriasis: a study of personality traits, anxiety and depression in psoriasisBritish Journal of Dermatology, 2013
- Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in ratsPhysiology & Behavior, 2013
- IL-1R1 Signaling Facilitates Munro’s Microabscess Formation in Psoriasiform Imiquimod-Induced Skin InflammationJournal of Investigative Dermatology, 2013
- Aldara activates TLR7-independent immune defenceNature Communications, 2013
- Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapiesJournal of the European Academy of Dermatology and Venereology, 2013
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 AxisThe Journal of Immunology, 2009